You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

“Yes! We Can End TB." World TB Day is March 24, 2023. Join us in the fight.
I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
Masthead
Masthead-mobile

Education

Our Education Center is your entry point into our library of educational webinars, websites and videos. Enjoy some of the selected highlights below or click through to explore.

Webinars

Simplification of testing and treatment in the quest to eliminate hepatitis C infection
WEBINAR

Simplification of testing and treatment in the quest to eliminate hepatitis C infection

Globally, 71 million people are living with hepatitis C virus (HCV) infection, but the burden of HCV continues to increase. Between 2015 and 2030, WHO targets include reducing new HCV infections by 80% and HCV deaths by 65%, and increasing HCV diagnoses from <20% to 90% and the number of eligible persons receiving HCV treatment from <10% to 80%. To achieve these targets, targeted interventions are needed to enhance HCV testing, linkage to care, and treatment (“the HCV care cascade”). This presentation reviews available evidence on strategies that have been successfully used to enhance HCV testing, linkage to care.

WEBINAR

Early diagnosis of HIV and use of molecular Point-of-Care HIV testing as part of a comprehensive strategy to end HIV transmission

According to UNAIDS1 the world is embarking on a Fast-Track strategy to end the AIDS epidemic by 2030. There is a strong global consensus that powerful tools now exist to end the AIDS epidemic.

WEBINAR

Bringing Molecular Testing Closer to the Patient

Over the past 20 years, there has been a continuous shift toward the decentralization of clinical laboratory testing. With recent advances in the speed and accuracy of point-of-care tests, it is now possible to bring molecular infectious disease testing closer to the patient. This webinar explores the benefits of molecular point-of-care testing as a means of improving patient outcomes and quality of care. Currently available testing methods are reviewed, with an emphasis on the importance of lab testing in the era of performance-driven healthcare.

See all webinars

Our Educational Sites

Get the Right Test

The flu season is variable and its impact widespread. This challenge is compounded by the coinciding RSV and Strep A season. On Get The Right Test, you can learn how rapid molecular testing can reduce collection-to-result time, decrease number the of tests performed, and support antimicrobial stewardship. Stay in the know by signing up for weekly flu tracker updates during the flu season.

Visit website

Diagnostics First

Each time a microorganism becomes resistant to an antibiotic, we lose another weapon in the war against infection. Fight back against antibiotic resistance with diagnostics first. Sign up today to receive customized, educational content and learn how on-demand molecular testing can help achieve your institution’s Infection Prevention and Antimicrobial Stewardship goals.

Visit website

C. Diff FAQs

C. difficile is the leading cause of gastroenteritis-associated death1 and is associated with approximately $5 billion in excess healthcare spending2. Given the importance of accurate detection and appropriate infection control measures, diagnostics play a critical role in the management of patients with clinically significant diarrhea.

Visit website

Videos

The GeneXpert® System: How Does it Help You Deliver Better Care?

Play

Xpert HCV VL Fingerstick - Near Patient Testing for Hepatitis C

Play

HPV Testing in Cape Town – See How One Clinic is Making a difference for Women

Play
See more videos

Connect To Better Outcomes

Request Info

1. https://www.ncbi.nlm.nih.gov/pubmed/22491338 Hall, AJ., et al. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis. 2012

2. https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html CDC Media Relations. Nearly half a million Americans suffer from C. difficile infections in single year. CDC Newsroom. 2015.

3. ModernMedicine Network. Chronic Myeloid Leukemia. Accessed Nov 27 2018. http://www.cancernetwork.com/chronic-myeloid-leukemia/chronic-myeloid-leukemia

4. Woessner, David W et al. Development of an effective therapy for chronic myelogenous leukemia. Cancer J. 2011;17(6):477-86. https://www.ncbi.nlm.nih.gov/pubmed/22157291

5. Goldberg S et al. Considerations for Successful Treatment-free Remission in Chronic Myeloid Leukemia. Clin Lymph, Myel & Leuk. 2017; 18(2):98-105. https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(17)30991-6/fulltext

Back to Top